The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases

QR Code

The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases

Neuroinflammation plays a crucial role in the progression of age-related and chronic neurological diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. This review examines the mechanisms of neuroinflammation by focusing on microglial and astrocyte activati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sharma Anurag, Khan Zoya, Nath Rajendra, Dixit Rakesh Kumar
Format:	Article
Language:	English
Published:	Sciendo 2025-06-01
Series:	Acta Marisiensis - Seria Medica
Subjects:	neuroinflammation neurodegenerative diseases pharmacological agents neuroprotection inflammatory pathways therapeutic targets
Online Access:	https://doi.org/10.2478/amma-2025-0018
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modulatory Effects of <i>Urtica dioica</i> on Neurodegenerative Diseases: Unveiling the Latest Findings and Applications Related to Neuroinflammation, Oxidative Stress, and Cognitive Dysfunction
by: Ahlem Chira, et al.
Published: (2025-07-01)

Decoding the role of large heat shock proteins in the progression of neuroinflammation‐mediated neurodegenerative disorders
by: Shailendra K. Saxena, et al.
Published: (2025-03-01)

Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases
by: Gang Wang, et al.
Published: (2025-07-01)

Exploring Non-Pharmacologic Adjunctive Therapies for Patients with Neurodegenerative Diseases
by: Maria Marchiș, et al.
Published: (2025-07-01)

Physical activity and neuroinflammation: a bibliometric analysis of research progress and future perspectives
by: Yeting Zhang, et al.
Published: (2025-08-01)

Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders
by: Mario García-Domínguez
Published: (2025-06-01)

Modulation of neuroinflammation by natural plant compounds: a promising approach for ischemic stroke
by: Pingping Niu, et al.
Published: (2025-07-01)

An Updated and Comprehensive Review Exploring the Gut–Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies
by: Ahmed Hasan, et al.
Published: (2025-06-01)

METABOLIC REPROGRAMMING OF MICROGLIA AND ASTROCYTES AS A FACTOR IN THE REGULATION OF NEUROINFLAMMATION IN ISCHEMIC STROKE
by: Mikhail Bobrov, et al.
Published: (2019-08-01)

Exploring GPR120/FFAR4 pharmacology: Unveiling novel therapeutic avenues through molecular signaling pathways for Alzheimer's disease intervention
by: Priyadharshini Gogu, et al.
Published: (2025-10-01)

Pharmacology of micronutrients /
by: Flodin, Nestor W. (Nestor Winston), 1915-
Published: (1988)

Stem cell extracellular vesicles: a new dawn for anti-inflammatory treatment of neurodegenerative diseases
by: Miao Yu, et al.
Published: (2025-07-01)

Neuroprotective Properties of Wild Mango (Mangifera caloneura Kurz) Leaves on Alleviating Urban Air Pollutant Toxicity: Insights From Transcriptome Analysis of a Human Neuronal Cell Model
by: Parinee Kittimongkolsuk, et al.
Published: (2025-07-01)

Pericyte-glial cell interactions: Insights into brain health and disease
by: Ali Sepehrinezhad, et al.
Published: (2026-04-01)

2024 international conference on neuroprotective agents conference proceedings
by: William Slikker, et al.
Published: (2025-07-01)

PANoptosis: Cross-Talk Among Apoptosis, Necroptosis, and Pyroptosis in Neurological Disorders
by: Li P, et al.
Published: (2025-06-01)

Nanopathways modulating postoperative cognitive dysfunction: extracellular vesicles
by: Yunmeng Zhang, et al.
Published: (2025-06-01)

Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
by: Neevashini Chengebroyen, et al.
Published: (2025-07-01)

Potential targets of microglia in the treatment of neurodegenerative diseases: Mechanism and therapeutic implications
by: Wenhui Zhao, et al.
Published: (2026-04-01)

Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD
by: Jiang Z, et al.
Published: (2025-07-01)

Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases
by: Renata Kołodziejska, et al.
Published: (2025-07-01)

Neuroinflammation in the Pathogenesis of Psychiatric Disorder
by: Eric Herlambang Sutantio, et al.
Published: (2025-05-01)

DRUG NEUROPROTECTION IN FULL-TERM NEWBORNS WITH SEVERE CEREBRAL ISCHEMIA
by: A. A. Zadvornov, et al.
Published: (2018-01-01)

Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases
by: Noah Drewes, et al.
Published: (2025-06-01)

Effects of Xenon on Neuroinflammatory Markers: a Prospective Pilot Study
by: A. I. Shpichko, et al.
Published: (2023-07-01)

Correction: Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease
by: Barbara Falquetto, et al.
Published: (2025-07-01)

Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease
by: Barbara Falquetto, et al.
Published: (2025-07-01)

Hydrogen Sulfide (H<sub>2</sub>S)-Donating Formyl Peptide Receptor 2 (FPR2) Agonists: Design, Synthesis, and Biological Evaluation in Primary Mouse Microglia Culture
by: Leonardo Brunetti, et al.
Published: (2025-07-01)

Effects of Selective α7 Nicotinic Acetylcholine Receptor Stimulation in Oligodendrocytes: Putative Implication in Neuroinflammation
by: Claudia Guerriero, et al.
Published: (2025-06-01)

Nanomedicine breakthroughs in cancer and neurodegenerative disease therapy
by: Abdul Haque, et al.
Published: (2025-01-01)

Traumatic Brain Injury and Neuroinflammation: Review of the Main Biomarkers
by: A. I. Zudova, et al.
Published: (2020-11-01)

Neuroanatomical mapping of huntingtin-associated protein 1 across the rostral and caudal clusters of mouse raphe nuclei and its immunohistochemical relationships with serotonin
by: Marya Afrin, et al.
Published: (2025-07-01)

Anti-inflammatory drugs from plant and marine sources /
by: Lewis, D. A. (David A.), 1932-
Published: (1989)

Carveol, a natural monoterpene from essential oils prevents neuronal impairments associated with murine Parkinson's disease model in rats
by: Ola A. Habotta, et al.
Published: (2025-08-01)

The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer’s disease
by: Xiaowen Sun, et al.
Published: (2025-06-01)

Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development
by: Aleksandar Dimkovski, et al.
Published: (2025-12-01)

Inflammation and Neurodegenerative Changes in Development of the Chronic Pathology of the Central Nervous System
by: V. M. Bondarenko
Published: (2011-12-01)

Immunomodulatory actions of tonifying polysaccharides: pharmacological effects, mechanisms and therapeutic applications
by: Jin-Yu Li, et al.
Published: (2025-07-01)

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications
by: Farah Anjum, et al.
Published: (2025-06-01)

The Role of Myeloid Differentiation Factor 2 in Stroke: Mechanisms and Therapeutic Potential
by: Deyuan Zhu, et al.
Published: (2025-07-01)